blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3562942

EP3562942 - MODIFIED CRISPR RNA AND USES THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  18.10.2021
Database last updated on 05.10.2024
FormerRequest for examination was made
Status updated on  04.10.2019
FormerThe international publication has been made
Status updated on  07.07.2018
Most recent event   Tooltip18.10.2021Application deemed to be withdrawnpublished on 17.11.2021  [2021/46]
Applicant(s)For all designated states
Ionis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad, CA 92010 / US
For all designated states
Ludwig Institute For Cancer Research
666 Third Avenue
New York, NY 10017 / US
[2019/45]
Inventor(s)01 / RAHDAR, Meghdad
2855 Gazelle Ct.
Carlsbad, CA 92010 / US
02 / PRAKASH, Thazha, P.
2855 Gazelle Ct.
Carlsbad, CA 92010 / US
03 / SWAYZE, Eric, E.
2855 Gazelle Ct.
Carlsbad, CA 92010 / US
04 / BENNETT, C., Frank
2855 Gazelle Ct.
Carlsbad, CA 92010 / US
05 / MCMAHON, Moira, A.
2855 Gazelle Ct.
Carlsbad, CA 92010 / US
 [2019/45]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2019/45]Holland, David Christopher
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
Application number, filing date17886910.328.12.2017
[2019/45]
WO2017US68642
Priority number, dateUS201662439828P28.12.2016         Original published format: US 201662439828 P
US201762491818P28.04.2017         Original published format: US 201762491818 P
US201762572361P13.10.2017         Original published format: US 201762572361 P
[2019/45]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018125964
Date:05.07.2018
Language:EN
[2018/27]
Type: A1 Application with search report 
No.:EP3562942
Date:06.11.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 05.07.2018 takes the place of the publication of the European patent application.
[2019/45]
Search report(s)International search report - published on:US05.07.2018
(Supplementary) European search report - dispatched on:EP10.11.2020
ClassificationIPC:C12N15/11, C12N15/10
[2020/50]
CPC:
C12N15/111 (EP,US); C12N15/102 (EP,US); A61P43/00 (EP);
C12N2310/20 (EP,US); C12N2310/315 (EP,US); C12N2310/321 (US);
C12N2310/322 (US); C12N2310/3231 (EP,US); C12N2310/346 (EP,US);
C12N2310/3521 (US); C12N2310/3533 (US); C12N2320/51 (EP,US) (-)
C-Set:
C12N2310/321, C12N2310/3521 (EP);
C12N2310/322, C12N2310/3533 (EP)
Former IPC [2019/45]C12N15/11, C12P19/34, C07H21/02
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/45]
TitleGerman:MODIFIZIERTE CRISPR-RNA UND DEREN VERWENDUNGEN[2019/45]
English:MODIFIED CRISPR RNA AND USES THEREOF[2019/45]
French:CRISPR-ARN MODIFIÉ ET SES UTILISATIONS[2019/45]
Entry into regional phase22.07.2019National basic fee paid 
22.07.2019Search fee paid 
22.07.2019Designation fee(s) paid 
22.07.2019Examination fee paid 
Examination procedure22.07.2019Examination requested  [2019/45]
23.03.2020Amendment by applicant (claims and/or description)
08.06.2021Application deemed to be withdrawn, date of legal effect  [2021/46]
29.06.2021Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time  [2021/46]
Fees paidRenewal fee
13.12.2019Renewal fee patent year 03
14.12.2020Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[IA]WO2016123230  (PIONEER HI BRED INT [US]) [I] 1-3,5-10,12-15 * figures 10-13; example 12; claims 1-4, 10 * * the whole document * [A] 4,11;
 [XAI]CN106244591  (SUZHOU GENEPHARMA CO LTD) [X] 1-3,6-8,12-14 * claims 1-10; table 1 * * the whole document * [A] 4,5,9-11 [I] 15;
 [XAI]WO2016205711  (BROAD INST INC [US], et al) [X] 1-4,6-8,10,12-15 * paragraphs [0225] , [ 324] * * the whole document * [A] 9,11 [I] 5;
 [XPI]WO2017004261  (IONIS PHARMACEUTICALS INC [US]) [XP] 1-8,10,12-15 * example 9; claims 164-273, 277-282, 285, 290 * * the whole document * [I] 9,11;
 [XP]WO2017181107  (OHIO STATE INNOVATION FOUNDATION [US]) [XP] 1-15 * figures 9, 15, 18; example 1; table 2 * * the whole document *;
 [E]WO2018098383  (INTEGRATED DNA TECH INC [US]) [E] 1-15 * figures 7, 8; tables 6-10 ** the whole document *;
 [XPI]  - BIN LI ET AL, "Engineering CRISPR-Cpf1 crRNAs and mRNAs to maximize genome editing efficiency", NATURE BIOMEDICAL ENGINEERING, (20170510), vol. 1, no. 5, doi:10.1038/s41551-017-0066, pages 1 - 21, XP055564263 [XP] 1-14 * the whole document * [I] 15

DOI:   http://dx.doi.org/10.1038/s41551-017-0066
 [P]  - BIN LI ET AL, "Engineering CRISPR-Cpf1 crRNAs and mRNAs to maximize genome editing efficiency - Suppl. Information", NATURE BIOMEDICAL ENGINEERING, (20170510), vol. 1, no. 5, doi:10.1038/s41551-017-0066, pages 1 - 19, XP055745200 [P] * figure S6; table S1 * * the whole document *

DOI:   http://dx.doi.org/10.1038/s41551-017-0066
International search[A]US2015376587  (MAY ANDREW PAUL [US], et al) [A] 1-5, 6/1-5, 7/1-5, 8/1-4 * ' *;
 [A]US2016024524  (JOUNG J KEITH [US], et al)[A] 1-5, 6/1-5, 7/1-5, 8/1-4;
 [X]US2016289675  (RYAN DANIEL E [US], et al) [X] 1-5, 6/1-5, 7/1-5, 8/1-4 * ; paragraphs [0022], ' [0025], [0042], [0048], [0057], [0063], [0171], [0173], [0254], [0293], [0294], [0393] *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.